TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis
2021 · Journal of Hepatology · 56 citations
https://doi.org/10.1016/j.jhep.2021.01.044
B
Bin-yong Liang
Tongji Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
1.2K
Citations
19
h-index
25
i10-index
Bin-yong Liang is an academic researcher from Tongji Hospital. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation. The author has an h-index of 19, co-authored 44 publications.
ORCID: 0000-0002-2415-2362Papers by this author
worksβ-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma
2022 · Gastroenterology · 45 citations
https://doi.org/10.1053/j.gastro.2022.04.028
Severity of liver cirrhosis: a key role in the selection of surgical modality for Child-Pugh A hepatocellular carcinoma
2015 · World Journal of Surgical Oncology · 34 citations
https://doi.org/10.1186/s12957-015-0567-9
Additional file 2: of α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7802720
Additional file 4: of α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7802738
Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancers
2024 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-5494074/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat